KRT18 and metabolic dysfunction-associated steatohepatitis: It is noteworthy that we can more easily diagnose NASH in combination with CK18-F even in cases with a low FIB-4, NFS score, or TE value [75–77], suggesting its ability to rule in NASH among patients rated at low or intermediate risk by clinically established NITs.